Nigeria

Resilience System


You are here

AstraZeneca seeks U.S. FDA authorisation of drug to prevent COVID-19

Primary tabs

 

Oct 5 (Reuters) - AstraZeneca (AZN.L) has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.

In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77%. ...

 

Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.387 seconds.